AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19627887 — intervention group
Group type: COMPARATOR
Intervention: Standard back pain education (group 1)
Number of subjects: 61
Study 19627887 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional physical therapy (group 2)
Number of subjects: 61
Study 19627887 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional movement training (group 3)
Number of subjects: 61
Study 16423355 — intervention group
Group type: EXPERIMENTAL
Intervention: Level one responders
Number of subjects: 3
Study 16423355 — intervention group
Group type: EXPERIMENTAL
Intervention: Level two responders
Number of subjects: 3
Study 16423355 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 3
Study 15531171 — intervention group
Group type: EXPERIMENTAL
Intervention: Traumatic Brain Injury (TBI) group
Number of subjects: 20
Study 15531171 — intervention group
Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 20
Study 11483268 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaqta
Number of subjects: 127
Study 11483268 — intervention group
Group type: COMPARATOR
Intervention: Avaxim
Number of subjects: 127
Study 9256119 — intervention group
Group type: EXPERIMENTAL
Intervention: Idarubicin 12 mg/m2/d for 3 days in combination with fludarabine and cytarabine
Number of subjects: 11
Study 9256119 — intervention group
Group type: COMPARATOR
Intervention: Fludarabine and cytarabine (loading dose of 10.5 mg/m2 followed by continuous infusion of 30.5 mg/m2/24 hours for 48 hours, followed by cytarabine loading dose 390 mg/m2, then continuous infusion 101 mg/m2/h for 72 hours)
Number of subjects: 11
Study 8491664 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse oximetry
Number of subjects: 0
Study 3321925 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75 micrograms alpha-calcidol (1 alpha(OH)D3) daily
Number of subjects: 65
Study 3321925 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 31228414 — intervention group
Group type: EXPERIMENTAL
Intervention: OB Nest (reduced-visit prenatal care model with remote monitoring)
Number of subjects: 300
Study 31228414 — intervention group
Group type: COMPARATOR
Intervention: Usual care (12 prescheduled prenatal clinic appointments)
Number of subjects: 300
Study 27207825 — intervention group
Group type: EXPERIMENTAL
Intervention: WE-CO2
Number of subjects: 240
Study 27207825 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2-CO2
Number of subjects: 240
Study 27207825 — intervention group
Group type: COMPARATOR
Intervention: WE-AI
Number of subjects: 240
Study 27207825 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 240
Study 27207825 — intervention group
Group type: EXPERIMENTAL
Intervention: WE
Number of subjects: 240
Study 24618113 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Contact Casts (TCC)
Number of subjects: 73
Study 24618113 — intervention group
Group type: COMPARATOR
Intervention: Shear-Reducing Boot (SRB)
Number of subjects: 73
Study 24618113 — intervention group
Group type: COMPARATOR
Intervention: Healing Sandals (HS)
Number of subjects: 73
Study 23746479 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 1445
Study 23746479 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel-eluting stenting (PES)
Number of subjects: 1445
Study 23746479 — intervention group
Group type: COMPARATOR
Intervention: Non-LAD PCI
Number of subjects: 1445
Study 22145450 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH therapy
Number of subjects: 0
Study 22145450 — intervention group
Group type: COMPARATOR
Intervention: Normal stature children (control)
Number of subjects: 0
Study 19770753 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose phospholipid emulsion (850 mg/kg)
Number of subjects: 1379
Study 19770753 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose phospholipid emulsion (1350 mg/kg)
Number of subjects: 1379
Study 19770753 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1379
Study 16855462 — intervention group
Group type: EXPERIMENTAL
Intervention: acute tryptophan-depleting (aTD) drink
Number of subjects: 27
Study 16855462 — intervention group
Group type: COMPARATOR
Intervention: nondepleting (nD) drink
Number of subjects: 27
Study 12616671 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone 0.5 mg twice daily
Number of subjects: 24
Study 12616671 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil 5 mg once daily
Number of subjects: 24
Study 12616671 — intervention group
Group type: EXPERIMENTAL
Intervention: Both drugs (Risperidone 0.5 mg twice daily and Donepezil 5 mg once daily)
Number of subjects: 24
Study 12616671 — intervention group
Group type: COMPARATOR
Intervention: All treatment groups
Number of subjects: 24
Study 10883569 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine-specific coping skills training (CST)
Number of subjects: 108
Study 10883569 — intervention group
Group type: COMPARATOR
Intervention: Control treatment (meditation-relaxation)
Number of subjects: 108
Study 9214205 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride 1 mg
Number of subjects: 25
Study 9214205 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride 5 mg
Number of subjects: 25
Study 9214205 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 8256189 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefepime (2 grams every 12 hours)
Number of subjects: 120
Study 8256189 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin (1.5 mg/kg every 8 hours) plus Mezlocillin (3 grams every 4 hours)
Number of subjects: 120
Study 8256189 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefepime
Number of subjects: 120
Study 8256189 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin and Mezlocillin
Number of subjects: 120
Study 3543180 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral decongestant-antihistamine combination and mucolytic preparation
Number of subjects: 38
Study 3543180 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 38
Study 30815761 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 month of online self-paced music training
Number of subjects: 41
Study 30815761 — intervention group
Group type: COMPARATOR
Intervention: 1 month of audiobook listening
Number of subjects: 41
Study 30815761 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 month of online self-paced music training followed by 1 month of audiobook listening
Number of subjects: 41
Study 30815761 — intervention group
Group type: COMPARATOR
Intervention: 1 month of audiobook listening followed by 1 month of music training
Number of subjects: 41
Study 27941535 — intervention group
Group type: EXPERIMENTAL
Intervention: EC-MPS
Number of subjects: 36
Study 25524227 — intervention group
Group type: EXPERIMENTAL
Intervention: Cage group 1
Number of subjects: 88
Study 25524227 — intervention group
Group type: EXPERIMENTAL
Intervention: Cage group 2
Number of subjects: 88
Study 24701663 — intervention group
Group type: EXPERIMENTAL
Intervention: First drop of cerebrospinal fluid
Number of subjects: 39
Study 24701663 — intervention group
Group type: EXPERIMENTAL
Intervention: Third drop of cerebrospinal fluid
Number of subjects: 39
Study 24701663 — intervention group
Group type: COMPARATOR
Intervention: Spinal needle
Number of subjects: 39
Study 21147414 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Thai massage (TTM)
Number of subjects: 36
Study 21147414 — intervention group
Group type: COMPARATOR
Intervention: Control (rest on bed)
Number of subjects: 36
Study 19917842 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone caseworker (TCW) model
Number of subjects: 356
Study 19917842 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 356
Study 19917842 — intervention group
Group type: EXPERIMENTAL
Intervention: Oncologist/general practitioner (O/GP) model
Number of subjects: 356
Study 17106543 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic myomectomy (LM)
Number of subjects: 36
Study 17106543 — intervention group
Group type: COMPARATOR
Intervention: Open myomectomy (AM)
Number of subjects: 36
Study 17106543 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 36
Study 15285974 — intervention group
Group type: EXPERIMENTAL
Intervention: Phased 'step-down' specialist psychosocial program (including a briefer residential stay and an outpatient component)
Number of subjects: 143
Study 15285974 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term psychoanalytically oriented residential specialist program
Number of subjects: 143
Study 15285974 — intervention group
Group type: COMPARATOR
Intervention: General community psychiatric model
Number of subjects: 143
Study 11853215 — intervention group
Group type: EXPERIMENTAL
Intervention: Marina (artificial mineral water containing K+ and Mg2+ ions), 4 x 200 ml daily for 7 days
Number of subjects: 0
Study 9757888 — intervention group
Group type: EXPERIMENTAL
Intervention: Unextracted urine measurement of FSH
Number of subjects: 40
Study 9757888 — intervention group
Group type: EXPERIMENTAL
Intervention: Storage conditions for urine
Number of subjects: 40
Study 7915076 — intervention group
Group type: EXPERIMENTAL
Intervention: Succinylcholine (1 mg.kg‐1) followed by vecuronium (0.15 mg.kg‐1)
Number of subjects: 54
Study 7915076 — intervention group
Group type: COMPARATOR
Intervention: Control group (no succinylcholine, vecuronium 0.15 mg.kg‐1)
Number of subjects: 54
Study 7915076 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (supplemental vecuronium 0.04 mg.kg‐1)
Number of subjects: 54
Study 2656959 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen, 10 mg/kg/dose, given at 8 AM, 12 PM, 4 PM, and 8 PM for 4 days.
Number of subjects: 72
Study 2656959 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 5015033 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 5 mg
Number of subjects: 100
Study 5015033 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg
Number of subjects: 100
Study 5015033 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyoscine 0.4 mg
Number of subjects: 100
Study 5015033 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyoscine 0.6 mg
Number of subjects: 100
Study 5015033 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 100
Study 5015033 — intervention group
Group type: COMPARATOR
Intervention: Pethidine 50 mg
Number of subjects: 100
Study 29036433 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with CAC
Number of subjects: 252
Study 29036433 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with LVH
Number of subjects: 252
Study 29036433 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with LVH and CAC
Number of subjects: 252
Study 29036433 — intervention group
Group type: COMPARATOR
Intervention: Patients without CAC and without LVH
Number of subjects: 252
Study 27220976 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored matched-message condition (N=356)
Number of subjects: 2140
Study 27220976 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-tailored unmatched-message condition (N=355)
Number of subjects: 2140
Study 27220976 — intervention group
Group type: COMPARATOR
Intervention: Typical message with professional design (Control, N=717)
Number of subjects: 2140
Study 27220976 — intervention group
Group type: COMPARATOR
Intervention: Typical message without professional design (Control, N=712)
Number of subjects: 2140
Study 25015838 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary care-based long-term program including discharge management, training of general practitioners and patients, and telephone monitoring.
Number of subjects: 290
Study 25015838 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary care-based long-term program
Number of subjects: 290
Study 25015838 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 290
Study 24421235 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential enteral nutrition (Group A)
Number of subjects: 49
Study 24421235 — intervention group
Group type: COMPARATOR
Intervention: Conventional enteral nutrition (Group B)
Number of subjects: 49
Study 20589596 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacotherapeutic management of aggression
Number of subjects: 0
Study 17964657 — intervention group
Group type: EXPERIMENTAL
Intervention: AcrySof intraocular lenses (IOLs)
Number of subjects: 1202
Study 16361856 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flux membranes
Number of subjects: 10
Study 16361856 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-flux membranes
Number of subjects: 10
Study 16361856 — intervention group
Group type: COMPARATOR
Intervention: Low-flux membranes
Number of subjects: 10
Study 16361856 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma carbonyl residues
Number of subjects: 10
Study 16361856 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced oxidation protein products (AOPPs)
Number of subjects: 10
Study 16361856 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between plasma-induced proapoptotic activity and plasma carbonyl levels
Number of subjects: 10
Study 16361856 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between plasma-induced proapoptotic activity and AOPP levels
Number of subjects: 10
Study 14521681 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up nursing interventions for patients with diabetes
Number of subjects: 0
Study 14521681 — intervention group
Group type: EXPERIMENTAL
Intervention: Rheumatology nurse specialist
Number of subjects: 0
Study 14521681 — intervention group
Group type: COMPARATOR
Intervention: Multidisciplinary team in day care or inpatient settings
Number of subjects: 0
Study 14521681 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple, long-term follow-up visits by nurses
Number of subjects: 0
Study 11049945 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac
Number of subjects: 10
Study 8913408 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose
Number of subjects: 25
Study 8913408 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose in combination with sulfonylureas
Number of subjects: 25
Study 1562921 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline (HS)
Number of subjects: 28
Study 1562921 — intervention group
Group type: COMPARATOR
Intervention: Ringer's lactate (RL)
Number of subjects: 28
Study 4083302 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 P.M. dosing with 800 mg of Uniphyl
Number of subjects: 16
Study 30449692 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 88
Study 30449692 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study 29557250 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal insulin (40 IU)
Number of subjects: 38
Study 29557250 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline-soaked gel foam)
Number of subjects: 38
Study 28300804 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptol
Number of subjects: 62
Study 28300804 — intervention group
Group type: COMPARATOR
Intervention: Noophen
Number of subjects: 62
Study 25357174 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,320-nm Nd:YAG laser treatment
Number of subjects: 10
Study 25357174 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment of cryogen cooling only
Number of subjects: 10
Study 23923184 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal exercises
Number of subjects: 0
Study 20836133 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural drainage with percussion (PD)
Number of subjects: 36
Study 20836133 — intervention group
Group type: EXPERIMENTAL
Intervention: Autogenic drainage (AD)
Number of subjects: 36
Study 20836133 — intervention group
Group type: COMPARATOR
Intervention: Both AD and PD
Number of subjects: 36
Study 18411009 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily Sleep Interference Scale (DSIS)
Number of subjects: 2158
Study 15737445 — intervention group
Group type: EXPERIMENTAL
Intervention: Spastic cerebral palsy group
Number of subjects: 20
Study 15737445 — intervention group
Group type: COMPARATOR
Intervention: Normal subjects (control group)
Number of subjects: 20
Study 12969711 — intervention group
Group type: EXPERIMENTAL
Intervention: N,O-carboxymethylchitosan (NOCC) - 200 mL of 1% NOCC gel followed by 100 mL of 2% NOCC solution
Number of subjects: 34
Study 12969711 — intervention group
Group type: COMPARATOR
Intervention: Ringer's lactate
Number of subjects: 34
Study 11029555 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid injections
Number of subjects: 336
Study 8730521 — intervention group
Group type: EXPERIMENTAL
Intervention: Positively worded statements
Number of subjects: 116
Study 8730521 — intervention group
Group type: EXPERIMENTAL
Intervention: Negatively worded statements
Number of subjects: 116
Study 8730521 — intervention group
Group type: EXPERIMENTAL
Intervention: Paired statements
Number of subjects: 116
Study 1378783 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow release gallopamil 100mg twice daily
Number of subjects: 13
Study 1378783 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 3514487 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg atenolol
Number of subjects: 28
Study 3514487 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg atenolol
Number of subjects: 28
Study 3514487 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.5 mg chlorthalidone
Number of subjects: 28
Study 3514487 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 50 mg atenolol and 12.5 mg chlorthalidone
Number of subjects: 28
Study 3514487 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 3514487 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of atenolol-chlorthalidone
Number of subjects: 28
Study 31882408 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsurgical periodontal treatment
Number of subjects: 0
Study 29972391 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive pressure group
Number of subjects: 0
Study 29972391 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory load group
Number of subjects: 0
Study 29972391 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 0
Study 27190356 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent in-center hemodialysis (6 times per week)
Number of subjects: 332
Study 27190356 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent nocturnal home hemodialysis (6 times per week)
Number of subjects: 332
Study 27190356 — intervention group
Group type: COMPARATOR
Intervention: Conventional hemodialysis (3 times per week)
Number of subjects: 332
Study 24472759 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain and gallbladder descriptors, psychosocial/functional disorder questionnaires
Number of subjects: 214
Study 24472759 — intervention group
Group type: EXPERIMENTAL
Intervention: Narcotics usage
Number of subjects: 214
Study 24472759 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic factors, gallbladder pathology, increased pancreatobiliary enzymes, functional disorders, and pain patterns
Number of subjects: 214
Study 24472759 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety and depression
Number of subjects: 214
Study 23212058 — intervention group
Group type: EXPERIMENTAL
Intervention: L-methylfolate (15 mg/day)
Number of subjects: 223
Study 23212058 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 223
Study 23212058 — intervention group
Group type: EXPERIMENTAL
Intervention: L-methylfolate (7.5 mg/day for 30 days followed by 15 mg/day for 30 days)
Number of subjects: 223
Study 23212058 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for 30 days followed by L-methylfolate 7.5 mg/day for 30 days)
Number of subjects: 223
Study 20642249 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl iontophoretic transdermal system (ITS)
Number of subjects: 1288
Study 21858581 — intervention group
Group type: EXPERIMENTAL
Intervention: Forward-training group
Number of subjects: 22
Study 21858581 — intervention group
Group type: EXPERIMENTAL
Intervention: Reverse-training group
Number of subjects: 22
Study 21858581 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 22
Study 15679718 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclesonide 160 microg
Number of subjects: 329
Study 15679718 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclesonide 640 microg
Number of subjects: 329
Study 15679718 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 329
Study 12895452 — intervention group
Group type: EXPERIMENTAL
Intervention: Alzheimer's disease patients
Number of subjects: 22
Study 9863872 — intervention group
Group type: EXPERIMENTAL
Intervention: Dideoxynucleoside monotherapy (zidovudine)
Number of subjects: 41
Study 9863872 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (zidovudine, zalcitabine, didanosine)
Number of subjects: 41
Study 9863872 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 41
Study 9863872 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall adherence
Number of subjects: 41
Study 7897523 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 drugs in 1 day regimen followed by high-dose methotrexate (12 g/m2)
Number of subjects: 68
Study 7897523 — intervention group
Group type: COMPARATOR
Intervention: Postirradiation chemotherapy with four 8/1 courses monthly
Number of subjects: 68
Study 7897523 — intervention group
Group type: COMPARATOR
Intervention: Comparison of radiation doses in Group B
Number of subjects: 68
Study 7897523 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment including sandwich chemotherapy
Number of subjects: 68
Study 2495900 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg sodium cromoglycate metered dose inhaler
Number of subjects: 139
Study 2495900 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg sodium cromoglycate metered dose inhaler
Number of subjects: 139
Study 2495900 — intervention group
Group type: COMPARATOR
Intervention: Placebo aerosol
Number of subjects: 139
Study 799981 — intervention group
Group type: EXPERIMENTAL
Intervention: New analgesic compound (propoxyphene, acetaminophen, caffeine, hydroxyzine)
Number of subjects: 40
Study 799981 — intervention group
Group type: COMPARATOR
Intervention: Plain acetaminophen
Number of subjects: 40
Study 30599803 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-task walking
Number of subjects: 70
Study 30599803 — intervention group
Group type: COMPARATOR
Intervention: Normal walking
Number of subjects: 70